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Contemporary issues paper
Using GRADE to reduce the theory-practice gap
Keywords: Evidence-Based Practice (MeSH), Evidence-Based Nursing (MeSH), GRADE, 
Research (MeSH)
One of the most enduring problems in nursing and nurse education is what has been referred to as 
the ‘theory-practice gap’.  This paper aims to demonstrate that the Grading of Recommendation, 
Assessment, Development and Evaluation (GRADE) Evidence to Decision Frameworks can be 
used to explain the complex link between evidence and other influencing factors on one side of the 
equation, and the clinical recommendations and decisions that are made by clinicians and patients 
on the other.  It further argues for the development of GRADE specifically for this purpose among 
the educational community.
Background
Although there is a widespread consensus that that practice and research should be more closely 
aligned, a solution as to how this might be achieved is less clear, particularly as this has been an 
issue for some considerable period of time.  Simplistic approaches of teaching ‘more’ or ‘better’ 
research are on their own a flawed response because there are fundamental problems with applying 
research directly to practice which these do not address.  These include: that research is usually 
done on samples to estimate an effect in populations to which individual patients may not belong or 
is highly context specific; there may be differences between effects at the population and individual 
level; that statistical tests often do not provide the information and cannot provide the surety that 
people desire; and that the uncertainty surrounding research results is not easy to interpret or 
explain.  
2
To further complicate matters there has recently been a move towards encouraging a more 
sophisticated use of evidence; replacing the rigid hierarchy of evidence with more dynamic 
approaches that allow for contextual issues to be incorporated into the assessment of a body of 
evidence rather than individual papers.  Such an approach recognises that although randomised 
controlled trials (RCTs) are generally a higher level of evidence than observational studies, the high 
level of control that makes this so also means that they are less likely to demonstrate effectiveness 
than observational studies unless the context of the study matches that of clinical practice.  This and
other methodological strengths and weaknesses mean that observational studies can, on occasions 
provide a higher level of evidence than RCTs (GRADE Working Group, 2013).  Systematic reviews
and meta-analyses are generally considered to form a higher level of evidence still, but their use 
introduces the additional complications of methodological, clinical and outcome heterogeneity. In 
addition to this there is a myriad of other factors to be taken into account when translating evidence 
in to practice recommendations at group or individual levels. 
Using Grading of Recommendation, Assessment, Development and Evaluation (GRADE) 
The GRADE guidelines have emerged as the predominant method of assessing in a transparent 
manner the quality (or certainty) of evidence and translating this into a strength of recommendation.
It does this by providing a framework for rating the importance of different outcomes as to whether 
they are critical, or important but not critical; and then making a judgment about the overall quality 
of the evidence for each.  Thus it is focused on outcomes rather than individual papers.
The GRADE approach states that when turning evidence into healthcare recommendations a 
number of criteria should be used, these include the strength of the evidence in the form of a 
judgement about the confidence in the magnitude of the estimate of effect, but it is not limited to 
that alone.  Other factors to be considered include the balance between desirable and undesirable 
outcomes, values and preferences about treatments, and the resources used (GRADE Working 
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Group, 2013).  When formulating public health, health system and health policy recommendations 
the World Health Organization recommend adding the importance or priority of the problem being 
addressed, equity and human rights considerations, the acceptability of the intervention and its 
feasibility to these (World Health Organization, 2014).  
This approach therefore explicitly acknowledges that healthcare recommendations need to be based 
on factors other than a simple critique and attempted implementation of research findings, an error 
that evidence-based practice courses which concentrate on research findings alone may make.  
Furthermore, the outcome of this process is more than a simple recommendation to do or not do 
something, it also allows for different strengths of recommendation: strong or weak for or against 
an intervention, or no recommendation if there is so much uncertainty that even a weak 
recommendation cannot be made.  Importantly the defining feature of a weak recommendation is 
that although most people would choose or be recommended a course of action, not all would 
choose it or benefit from it (GRADE Working Group, 2013).  This makes the existence of different 
responses to the same evidence explicit, and where variation is therefore likely to be appropriate.
This approach also allows for one to make stronger recommendations than one might otherwise 
make just based on study outcomes using an overall assessment of all of these influencing factors. 
For example, data showing that exercise led to a relatively small standardised mean reduction in 
depression symptoms at follow-up of -0.33 [95% CI: -0.63, -0.03 ] compared to control treatments; 
and an even smaller and statistically non statistically significant reduction of -0.11 [-0.34, 0.12 ] 
compared to pharmacological treatments and -0.03 [-0.32, 0.26 ] compared to psychological 
therapies post-treatment (Cooney et al., 2013) could still result in a recommendation for this 
treatment when the other GRADE criteria are included.  If one considers the relative desirable and 
undesirable effects of the treatments there are likely to be very few undesirable effects associated 
with exercise and other positive effects such as improved fitness.  Patients might also like an 
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exercise regime, and it may also be cost effective.  Based on the same outcome data one may not 
recommend a pharmacological treatment as first-line therapy where there might be significant 
adverse effects however.  
Such a judgment is reflected in the draft United Kingdom National Institute of Health and Care 
Excellence (NICE) Guidance on Depression in adults: treatment and management, where a new 
recommendation is to “Consider a physical activity programme specifically designed for people 
with depression as an initial treatment for people with less severe depression” (National Institute for
Health and Care Excellence, 2018, p.262).  Note the use of the word ‘consider’ in this sentence 
which NICE use when the balance between benefits and harms is small and so the recommendation 
is made with less certainty.  In this case there are few obvious harms, but the benefit is small and the
wide confidence interval that in some cases encompasses the null value (zero) mitigate against a 
stronger recommendation.  A weak recommendation suggests that not all individuals would choose 
or be best treated by the recommended course of action and so greater consideration of individual 
factors may be needed to help decide (GRADE Working Group, 2013). 
Evidence to Decision Frameworks
However, even where clear evidence or guidance exists, recommendations do not implement 
themselves.  To help with this some guideline development groups produce implementation tools, 
for example those produced by NICE. Although these can be helpful they may not get over the 
problem of applying group level guidance or evidence to individual patients in specific contexts. 
For this purpose Evidence to Decision Frameworks may be helpful both in making decisions and 
explaining any apparent contradiction between research evidence and clinical practice; 
remembering that under GRADE the quality of evidence in the form of an assessment of one’s 
confidence in the estimate of effect supports a particular recommendation is only one factor in 
making a recommendation.
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The GRADE Evidence to Decision Framework recognises that there are a number of different types
of decision, including clinical recommendations, coverage decisions, health system and public 
health recommendations, and diagnostic screening and other test recommendations, which are 
implemented at both the individual and population levels (Moberg et al. 2018).  It is important to 
remember the level at which evidence applies; guidance is usually produced at a population level 
(for example people with type 1 diabetes) but implemented at sub-group level (people with diabetes
at a particular clinic) or individual level (an individual with diabetes).
For clinical decisions at the population level there are twelve criteria to be considered, while at the 
individual level there are ten (Alonso-Coello et al. 2016); the individual level criteria being:
 Is the problem a priority?  Healthcare professionals are used to prioritising care; but it is 
important to remember that patients may not attach the same priorities to problems as those 
treating them.  
 How substantial are the desirable anticipated effects?  A treatment with greater desirable 
effects is more likely to be recommended and to receive a strong recommendation, as well 
as being acceptable to patients.  This assessment should include both frequency and 
magnitude of effect, using absolute numbers where possible and the likely importance of the
outcome.
 How substantial are the undesirable anticipated effects?  Using the same rationale to that 
above, a treatment with greater undesirable effects is less likely to be recommended and to 
receive a strong recommendation, as well as being to be acceptable to patients
 What is the overall certainty or quality of the evidence of effects?  This requires an 
assessment of the certainty attached to outcome estimates, both negative and positive.  This 
can be assessed using the main GRADE criteria for quality of evidence; and uncertainty 
would reduce the strength of any recommendation.
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 Is there important uncertainty about or variability in how much people value the main 
outcomes?  If there is uncertainty about how much patients or carers value the outcomes or 
if those with different values would make different decisions, this might reduce the strength 
of any recommendation.  Thus the patient voice is central in this process; they are not 
simply a member of a sample or population.
 Does the balance between desirable and undesirable effects favour the intervention or the 
comparison?  This should take into account the previous four questions (magnitude of 
desirable and undesirable effects, certainty of the evidence of these, and the value attached 
to the outcomes) and seek to make a judgment on the overall balance between the desirable 
and undesirable effects.
 Does the cost effectiveness of the intervention favour the intervention or the comparison?  
There is a difference here between individual and group-level decisions as to whether this is 
assessed as the costs to the service, costs to the patient, or both.  The nature of this 
assessment is also likely to depend on the way that healthcare costs are allocated between 
patient and provider, but in most circumstances the greater the costs the less likely a strong 
recommendation is. In some cases costs are critical to a recommendation.
 What would be the impact on health equity?  Interventions should always seek to reduce 
inequity; for example by reducing barriers to access by cost or geography.
 Is the intervention acceptable to patients, their care givers, and healthcare providers?  
Acceptability can be influenced by many things, most commonly it is a mixture of the 
balance between the balance of desirable and undesirable effects, and associated financial 
costs.
 Is the intervention feasible for patients, their care givers, and healthcare providers?  
Feasibility may differ according to settings, for example what might be possible in an RCT 
conducted in a large tertiary centre might be wildly different to a small local hospital or an 
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uncontrolled treatment as might be given in a general clinic.  Patients may also not be able 
to comply with the treatment.
The main difference between the individual and population perspectives are that in the latter cost 
effectiveness is broken down into the size of resource requirements, the certainty of the evidence of 
resource requirements, and the cost effectiveness of the intervention at a population level rather 
than focusing on the individual (Alonso-Coello et al. 2016).
Other considerations that might be used include:
 Any other evidence that may be useful but which is outside of the normal evidence 
hierarchy.
 Plausible consequences even when evidence is lacking, for example effects on equality or 
access, or likely difficulties with implementation.
 Explanation of any assumptions made.
 Clear explanation of the reasons for a judgment if this does not clearly reflect research 
evidence.
 The need to document the voting results or any discussions by the panel that affect the 
decision (Alonso-Coello et al. 2016).
Thus it is clear that clinicians and patients might make different decisions based on contextual and 
individual factors, which while informed by research evidence is not dependent on that alone. 
Additionally it emphasises the importance of really understanding how the application of group 
level guidance to individuals is carried out.
An example – fever in children
One area where there is considerable variation from recommended practice is in the treatment of 
fever in children with antipyretic medicines. Guidance around the world recommends this only for 
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distress (National Institute for Health and Care Excellence, 2013) or to improve the child’s comfort 
(Sullivan et al. 2011), yet their use is much more widespread among parents and professionals. 
Although there appears to be a clear gap between theory and practice, application of the Evidence to
Decision Framework explains why this may be the case and demonstrates the complexity of theory 
behind the practice and the decision-making processes that may be occurring (Table 1).  There is 
therefore probably less of a theory-practice gap than it might first seem, it is just that practice 
includes other factors in addition to research evidence.  Once students and staff understand that 
research itself is full of uncertainty, the importance of contextual issues become clearer.
Conclusion
Translating research into practice is much more complex than simply attempting to read and apply 
research findings.  Although clinicians instinctively know this and tools such as GRADE make this 
clear, the Evidence to Decision Frameworks are relatively new and their full potential in teaching 
perhaps not appreciated.  Using these allows nurses to understand the multiplicity of factors that go 
into decision-making, and may help to explain why practice does not always appear to reflect 
evidence as well as equipping nurses with a knowledge of a now standard set of tools.
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Criterion Application to fever
Is the problem a priority (from the 
perspective of individual patients)?
Although fever does not need treating itself, both 
parents and professionals worry about it
How substantial are the desirable 
anticipated effects?
Reduction of fever may ease discomfort and pain
How substantial are the undesirable 
anticipated effects?
Use of antipyretics may exacerbate anxiety by 
implying that fever needs treatment, small 
possibility of adverse effects
What is the overall certainty of the 
evidence of effects?
Strong evidence for reduction in fever and pain
Is there important uncertainty about or 
variability in how much people value the
main outcomes?
Clear evidence that parents and professionals 
value fever reduction
Does the balance between desirable and 
undesirable effects favour the 
intervention or the comparison?
Neither
Does the cost effectiveness of the 
intervention (the out-of-pocket cost 
relative to the net desirable effect) favour
the intervention or the comparison?
Some cost associated with medicines, although in 
the UK on prescription it is free to children.  On a
population level this cost may be substantial if 
widely prescribed.
What would be the impact on health 
equity?
No significant
Is the intervention acceptable to patients,
their care givers, and healthcare 
providers?
Antipyretics are popular medicines
Is the intervention feasible for patients, 
their care givers, and healthcare 
providers?
Yes, the medicines are relatively straightforward.
Table 1. Explaining theory-practice gap using the GRADE Evidence to Decision Framework
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